Literature DB >> 22280511

Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis.

I M Haeck1, O ten Berge, S G A van Velsen, M S de Bruin-Weller, C A F M Bruijnzeel-Koomen, M J Knol.   

Abstract

BACKGROUND: Studies assessing the relationship between disease activity and quality of life (QoL) in adults with atopic dermatitis (AD), before and after therapy are lacking. The relation between disease activity and QoL in AD patients was evaluated before (t = 0) and after 6 weeks (t = 6) of treatment with cyclosporin 5 mg/kg.
METHODS: In 54 patients with severe AD, disease activity was assessed using objective Scoring Atopic Dermatitis index (SCORAD), Six Area Six Sign Atopic Dermatitis (SASSAD), 'rule of nines' extent score and serum levels of thymus and activation-regulated chemokine (TARC). Patients filled out the Dermatology Life Quality Index (DLQI). To study the relation between disease activity and QoL, correlations were calculated and regression analysis was performed.
RESULTS: At t = 0 there was a small, non-significant correlation between the DLQI and the objective SCORAD, 'rule of nines' or serum TARC levels. At t = 6 the objective SCORAD, serum TARC and the 'rule of nines' score showed moderate and significant correlations with the DLQI (r = 0.34, P = 0.02; r = 0.31, P = 0.03; r = 0.49, P < 0.001). An individual's improvement in disease activity (objective SCORAD, SASSAD and 'rule of nines') with 10 points was associated with an improvement of 1.3, 1.5 and 1.1 points respectively in DLQI.
CONCLUSIONS: Disease activity correlated better with QoL when disease activity was less severe and disease extent ('rule of nines') correlated better with QoL than disease severity. An individual's improvement of 10 points in disease activity was accompanied by only a small improvement in QoL. Other factors than disease activity may influence QoL in patients with AD.
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2011        PMID: 22280511     DOI: 10.1111/j.1468-3083.2011.04043.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

Review 1.  Selected comorbidities of atopic dermatitis: Atopy, neuropsychiatric, and musculoskeletal disorders.

Authors:  Jonathan I Silverberg
Journal:  Clin Dermatol       Date:  2017-03-24       Impact factor: 3.541

Review 2.  Targeting key proximal drivers of type 2 inflammation in disease.

Authors:  Namita A Gandhi; Brandy L Bennett; Neil M H Graham; Gianluca Pirozzi; Neil Stahl; George D Yancopoulos
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

3.  Severity strata for five patient-reported outcomes in adults with atopic dermatitis.

Authors:  P P Vakharia; R Chopra; R Sacotte; N Patel; S Immaneni; T White; R Kantor; D Y Hsu; E L Simpson; J I Silverberg
Journal:  Br J Dermatol       Date:  2018-03-06       Impact factor: 9.302

4.  Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization.

Authors:  Jonathan I Silverberg; Eric L Simpson
Journal:  Pediatr Allergy Immunol       Date:  2013-06-16       Impact factor: 6.377

5.  Measurement properties of three assessments of burden used in atopic dermatitis in adults.

Authors:  K R Patel; V Singam; P P Vakharia; R Chopra; R Sacotte; N Patel; S Immaneni; R Kantor; D Y Hsu; J I Silverberg
Journal:  Br J Dermatol       Date:  2018-11-12       Impact factor: 9.302

6.  Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States.

Authors:  Raj Chovatiya; Wendy Smith Begolka; Isabelle J Thibau; Jonathan I Silverberg
Journal:  Arch Dermatol Res       Date:  2021-09-27       Impact factor: 3.033

7.  Patient Education Programs in Pediatric Atopic Dermatitis: A Systematic Review of Randomized Controlled Trials and Meta-Analysis.

Authors:  Mutong Zhao; Yuan Liang; Chunping Shen; Ying Wang; Lin Ma; Xiuhua Ma
Journal:  Dermatol Ther (Heidelb)       Date:  2020-03-21

8.  Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review.

Authors:  Trisha Kaundinya; Uros Rakita; Armaan Guraya; Donna Maria Abboud; Emily Croce; Jacob P Thyssen; Andrew Alexis; Jonathan I Silverberg
Journal:  J Invest Dermatol       Date:  2021-08-02       Impact factor: 8.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.